Stacy M. Goins

Oct 4, 2024 | resmedjournal.com | Madison Wulfeck |David G. Mummy |Shuo Zhang |Diana Kadi |Stacy M. Goins |Aparna Swaminathan | +3 more

Keywordsinterstitial lung disease129Xe MRIchronic hypersensitivity pneumonitishigh-resolution computed tomographyINTRODUCTIONThe spectrum of fibrotic interstitial lung diseases (ILDs) is characterized by inflammation and scarring of the lung parenchyma, which can lead to end-stage fibrosis. The significant heterogeneity in ILDs presents challenges in differentiating chronic hypersensitivity pneumonitis (CHP) from other fibrotic ILDs, specifically idiopathic pulmonary fibrosis (IPF) [1,2].